Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: J Hosp Med. 2023 Aug 22;18(10):896–907. doi: 10.1002/jhm.13193

Table 3.

Relationship between Domain Summary Scores and Readiness Status for Initiating Buprenorphine and Methadone for Hospitalized Patients with OUD

Buprenorphine Methadone
Domain with Prepopulate Response All Mean (SD) Higher Readiness N = 72 Lower Readiness N = 88 P Valuea All Mean (SD) Higher Readiness N = 55 Lower Readiness N = 105 P Value
Domain 1: Perceived validity of the evidence to treat OUDc 4.19 (0.75) 4.42 (0.61) 4.00 (0.80) <0.001b 4.19 (0.75) 4.56 (0.52) 4.00 (0.78) <0.001b
Domain 2: Satisfaction with hospital processes for OUD screening, treatment, and linkagec 3.03 (0.96) 3.12 (0.96) 2.94 (0.97) 0.236 3.03 (0.96) 3.17 (0.93) 2.95 (0.97) 0.161
Domain 3: Perceived barriers to use the medicationd 0.32 (0.22) 0.24 (0.24) 0.39 (0.22) <0.001 0.34 (0.23) 0.21 (0.18) 0.41 (0.23) <0.001
Domain 4: Current clinical practices for OUD treatmentc 2.73 (0.97) 3.07 (0.97) 2.45 (0.88) <0.001 2.73 (0.97) 3.35 (0.96) 2.40 (0.81) <0.001
Domain 5: Perceived hospital leadership support to treat OUD in the hospitalc 2.77 (0.96) 2.99 (0.92) 2.58 (0.96) 0.006 2.77 (0.96) 3.07 (0.90) 2.61 (0.96) 0.003
Domain 6: Job satisfactionc 3.67 (0.75) 3.81 (0.73) 3.55 (0.75) 0.022b 3.67 (0.75) 3.92 (0.64) 3.54 (0.77) 0.005b
a

All tests for continuous variables were independent t-tests unless superscripted with “b” in which case they were Chi-square tests

c

Summary score range is 1 to 5

d

Summary score range is 0 to 1